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Abstract
We have studied the interaction of the Gal-GalNAc-reac-
tive champedak lectin-C with neuraminidase-treated and
untreated IgA1 from IgA nephropathy patients. The bind-
ing ability of the lectin to untreated IgA1 from IgA
nephropathy patients was significantly lower as com-
pared to the untreated IgA1 from normal controls. This
differential lectin-binding capacity was abrogated when
the experiment was performed on neuraminidase-
treated sera. Treatment of the serum IgA1 with neur-
aminidase also abrogated the differential charge distri-
bution between the ·-heavy chains of IgA nephropathy
patients and normal controls.
Copyright © 2001 S. Karger AG, Basel
Introduction
The idea that the abnormality of the O-glycans of IgA1
would cause the immunoglobulin deposition in the kid-
ney mesangium of IgA nephropathy (IgAN) patients re-
ceives support from numerous experiments. The bind-
ing of IgA1 to different cells and tissues is influenced by
the structures of the hinge region O-linked oligosaccha-
ride moieties. Modification of the structures of the O-
glycans was demonstrated to cause profound alteration
in the binding ability of IgA1 to cells of the liver and
kidney [1].
Lectin-binding studies have established the difference
between the structures of O-linked oligosaccharides of
IgA1 between IgAN patients and normal controls. IgA1
from the sera of patients with IgAN displayed a decreased
binding to the Gal-GalNAc-reactive jackfruit lectin, jacal-
in [2, 3]. The patients’ IgA1 was also reported to contain
relatively higher asialo-Gal-GalNAc moieties [4]. When
the ·-heavy chains of IgA1 from IgAN patients’ sera was
analyzed for their charges and compared to that of normal
controls, the distribution of charge was found to be signifi-
cantly higher at the cationic region [5].
In the present study we have investigated the effect of
neuraminidase treatment on IgA1 from patients with
IgAN, in terms of its interaction with the Gal-GalNAc-
reactive champedak lectin-C as well the charge distribu-
tion pattern of its ·-heavy chains.
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Materials and Methods
Sera
Serum samples were obtained from 10 IgAN outpatients (age
range 22–58 years) of the University Hospital, Kuala Lumpur, and
10 normal healthy adult volunteers (age range 20–42 years). The sub-
jects came from different ethnic backgrounds (Malay, Chinese and
Indian). Neuraminidase treatment of sera was performed at 35°C for
24 h in acetate buffer, pH 5.0, using the enzyme from Vibrio cholerae
(Sigma Chemical Co., St. Louis, Mo., USA).
Lectin
The isolation of lectin-C was performed by subjecting the crude
extract of champedak seeds to immobilized galactose-Sepharose
affinity chromatography as previously described [5]. Lectin-C was
conjugated to horseradish peroxidase (HRP) by incubation of the
purified lectin with periodate-activated HRP in sodium carbonate
buffer, pH 9.5, for 2 h at room temperature. The solution was stirred
for another 2 h at 4°C upon addition of sodium borohydrate to
reduce the remaining free enzymes. The conjugated lectin was kept at
4°C in the presence of 60% (v/v) glycerol.
Interaction of Champedak Lectin-C with Serum IgA1
The wells of the microtiter plate were coated with 0.5 Ìg/ml anti-
human IgA in phosphate-buffered saline (PBS) with 0.5% Tween-20
for 18 h at 4°C. The wells were subsequently blocked with 1% (w/v)
bovine serum albumin in PBS for 1 h at 4°C. Serum samples, with
their IgA concentrations standardized to 40 Ìg/ml, were added to the
wells and incubated at room temperature for 2 h. The interaction
between serum IgA1 with champedak lectin-C was tested by addition
of optimal concentration of the enzyme-conjugated lectin, deter-
mined based on the results of a chequered-board ELISA. For color
development, 0.04% (w/v) o-phenylenediamine and 0.008% (v/v)
H2O2 in phosphate-citrate buffer were added. The plate was incu-
bated at room temperature in the dark for 15 min. The reaction was
stopped by addition of 3 M HCl. The plate was read at 492 nm by
using the ELISA reader.
Analysis of the Charge Distribution Ratio of Asialo-·-Heavy
Chains
To determine the charge distribution of neuraminidase-treated
·-heavy chains of IgAN patients and normal controls, we have adopt-
ed a previously described experimental strategy [5]. The method
involved separation of sera by two-dimensional (2-D) gel electropho-
resis, their transfer onto nitrocellulose membrane and the detection
of the asialo-·-heavy chain band by using HRP-conjugated champe-
dak lectin-C. Position of the asialo-·-heavy chan band was initially
detected using enzyme-conjugated anti-human IgA1 (Binding Site,
Birmingham, UK). Distribution of the specific regions of the ·-heavy
chain band was analyzed in terms of volume, i.e., optical density !
area in square millimeters of region performed by using the comput-
erized Molecular Analyst densitometry software (Bio-Rad, Hercules,
Calif., USA) subsequent to an automated background optical density
subtraction.
Statistical Analysis
All values are presented as mean B SD. The Mann-Whitney U-
test was used to analyze the significant differences between normal
subjects and patients. A p value !0.05 was considered significant.
Fig. 1. Interaction of champedak seed lectin-C with serum IgA1.
Serum samples were initially standardized for IgA concentration at
40 Ìg/ml. The sera were incubated in a microtiter plate coated with
anti-IgA, in triplicate. The O-glycan moieties in the retained IgA1
were detected with HRP-conjugated lectin-C at 0.06 Ìg/ml.
Results
Interaction of Lectin-C with Neuraminidase-Treated
and Untreated Serum IgA1
In this study, the interaction of champedak lectin-C
with standardized concentrations of serum IgA1 of nor-
mal controls and IgAN patients was initially investigated.
The average absorbance reading for IgAN patients was
significantly lower (1.146 B 0.146) as compared to that of
normal subjects (1.320 B 0.095) (fig. 1). When the experi-
ment was repeated using neuraminidase-treated sera, the
difference between the values obtained from patients and
normal controls was no longer significant (fig. 2). The
average absorbance readings for normal subjects and
patients with IgAN were 0.750 B 0.093 and 0.749 B
0.090, respectively.
Charge Distribution of Neuraminidase-Treated
·-Heavy Chains
The anionic:cationic region distribution ratio of the
asialo-·-heavy chains of IgA1 from IgAN patients and
normal controls was determined by subjecting neuramini-
dase-treated serum samples to an analytical strategy as
described in our previous report [5]. Neuraminidase treat-
ment had apparently shifted the position of the asialo-·-
heavy chain spots to the positive side of the 2-D gel. When
the distribution of charge of the asialo-·-heavy chains of
IgA1 was analyzed by using the pI of 5.6 as a midpoint as
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Fig. 2. Interaction of champedak seed lectin-C with neuraminidase-
treated serum IgA1. Serum samples were treated with neuraminidase
from V. cholerae for 24 h at 35°C in acetate buffer, pH 5.0. The bind-
ing study was performed in the same manner as described in the
legend of figure 1.
Fig. 3. Mean anionic:cationic ratio of the total asialo-·-heavy chain
band from normal healthy controls and IgAN patients. The 2-D sepa-
rated ·-heavy chain band of neuraminidase-treated IgA1 was de-
tected by using enzyme-conjugated champedak lectin-C. A pI of 5.6
was used to divide the band into its anionic (pI !5.6) and cationic
regions (pI 15.6) according to previously adopted methods [5–7].
There was no significant difference between the mean ratio of vol-
ume distribution of anionic:cationic regions of the asialo-·-heavy
chains from normal controls (0.148 B 0.088) and IgAN patients
(0.155 B 0.058).adopted by previously described methods [5–7], there was
no significant difference between the anionic-cationic ra-
tio obtained for the IgAN patients (0.148 B 0.088) and
that of normal controls (0.155 B 0.058) (fig. 3).
Discussion
Champedak lectin-C is a plant lectin that binds to the
O-glycans of IgA1 similar to jacalin [8, 9]. In this study,
we have demonstrated that the affinity of the champedak
lectin-C to serum IgA1 was significantly weaker in pa-
tients with IgAN as compared to normal controls. Our
data are compatible with the earlier reports of Andre et al.
[2] and Mestecky et al. [3] using jacalin. The decreased
binding of the IgA1 from IgAN patients to the Gal-Gal-
NAc-reactive champedak lectin-C implies that the O-gly-
cans of the immunoglobulins were generally lacking in
Gal residues, either exclusively or with sialic acid resi-
dues. When the lectin-binding assay was repeated using
neuraminidase-treated sera, the differential binding abili-
ty between the asialo-IgA1 from IgAN patients and nor-
mal controls was no longer significant. The data indicate
that sialic acid residues provide significant contribution
to the affinity difference of champedak lectin-C binding
to the O-glycans of IgA1 between patients and normal
controls.
In our previous report, we have demonstrated that the
·-heavy chains of IgAN patients were generally more cat-
ionic as compared to the ·-heavy chains of normal
healthy controls [5]. In this study, we have extended the
previous investigation by repeating the experiments using
neuraminidase-treated sera. Our data demonstrate that
the distribution of charge of the asialo-·-heavy chains of
IgA1 was not significantly different between the IgAN
patients and normal healthy controls. The abrogation of
the differential charge distribution of the ·-heavy chains
between patients and normal controls by neuraminidase
treatment provides direct evidence for the differences in
the quantity of their sialic acid residues.
Taken together, the data of our present study indicate
that the binding abnormality of IgA1 from IgAN patients
and the differential charge distribution of its ·-heavy
chains are attributed to the differences in their sialic acid
residue content. This is in agreement with the report of
Hiki et al. [4] which demonstrated that the hinge-region
IgA1 of IgAN patients contained a relatively higher con-
centration of asialo-Gal-GalNAc moieties when com-
pared with control IgA1. The lower degree of IgA1 sialyla-
tion may be due to the effects of elevated levels of IL-4
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and IL-5 in the IgAN patients [10]. A deficiency of sialic
acid residues may induce a conformational instability to
the IgA1 molecule. IgA1 low in sialic acid residues has
been shown to have profiles similar to the heat-labile IgA1
[11]. The abnormalities of the hinge-region O-glycans
may result in autoaggregation in a similar manner to the
IgG molecules in rheumatoid arthritis [12].
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